Spinal FrontiersPowered by NSpineWeekly alert sign-up
← Back

Spinal Frontiers · Regulatory Watch · FDA decision

FDA approves Spineart's BAGUERA C cervical disc for one or two levels

FDA decision · Spineart

10 August 2026

FDA granted premarket approval for the BAGUERA C artificial disc for reconstruction at one or two contiguous levels from C3 to C7 in patients with radiculopathy or myelopathy after failed conservative care. A post-approval study protocol was approved on 22 September.

Type
FDA decision
Company
Spineart
Device
BAGUERA C Cervical Disc Prosthesis
Date
10 August 2026
Jurisdiction
US
Classification
PMA P250042 (original approval)
Source
FDA PMA database

Official source →Source checked

More from Regulatory Watch on Spineart

Other FDA decisions

← All of Regulatory Watch

Clinical PracticeLiterature WatchPatent WatchBooksGuideline LibraryCase of the MonthGuest EditorRare DiseasesReport a Device ProblemSafety in FocusSecure MessagingViewing Scans (DICOM)Measurement AppsCoding & ReimbursementVeterinary SpineSpine PodcastsGet Involved
Training & CareersTrainee HubFellowshipsJobsGet InvolvedSpine Podcasts
ResearchTrials WatchSpine RegistriesSpine JournalsFunding CallsSpine Podcasts
Medtech & InnovationIndustry RoundupProduct DevelopmentsRegulatory WatchImplant SystemsHow It's MadeAI & Emerging TechOff Duty: Podcasts for RepsSpine Theatre BuilderSpine MarketsCoding & Reimbursement
Meetings & SocietiesConferences & CoursesAbstract DeadlinesSpine Societies Worldwide
Spine Team & Allied HealthFor the Spine TeamSpine AnaesthesiaNeuromonitoringPain MedicineTheatre SafetyHalo TractionSpine PodcastsGet Involved
WellbeingHealth & NutritionBody & MindSupplementsMental Health for Clinicians
About & editorial policyFeedbackWeekly alert sign-upBack issuesPrivacy noticeDon't count my visitsLegal noticeCorrections for companiesAdvertise with usPartner OffersSearchUse as an app

Spinal Frontiers is published by NSpine Limited, registered in England and Wales (company no. 08362634), 14 Park Row, Nottingham NG1 6GR, United Kingdom. Every item is summarised in our own words and links to its original source. Listings are a selection made at NSpine's editorial discretion and are not exhaustive; inclusion is not an endorsement, and omission implies nothing. Sponsors and advertisers have no influence on what we cover. Nothing here is medical, legal or financial advice. Spotted an error or a broken link? Email spinalfrontiers@nspine.com, or use the feedback page.

Spinal Frontiers is a trademark of NSpine GmbH.

Information only, summarised from third-party sources: not medical, legal, regulatory or financial advice. Full disclaimer.

© 2013 – 2026 NSpine Limited. Privacy notice.